Donnie Rudd
Profile
Dr. Donnie Rudd is Chief Scientific Officer at Regenetech, Inc. and Chief Scientist & Director-Intellectual Property at Endonovo Therapeutics, Inc.
He received his undergraduate degree from Texas A&M University and a graduate degree from the Chicago-Kent College of Law.
Former positions of Donnie Rudd
| Companies | Position | End |
|---|---|---|
| ENDONOVO THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | - |
Regenetech, Inc.
 Regenetech, Inc. Miscellaneous Commercial ServicesCommercial Services Regenetech, Inc. develops and distributes tissue regeneration technology. It provides research and development services for adult stem cells expansion and therapeutic applications. The firm offers umbilical cord and peripheral blood expansion, bone regeneration, and biomolecules producing therapeutic technologies. The company was founded in April, 2002 and is headquartered in Houston, TX. | Chief Tech/Sci/R&D Officer | - |
Training of Donnie Rudd
| Texas A&M University | Undergraduate Degree |
| Chicago-Kent College of Law | Graduate Degree |
Experiences
Positions held
Linked companies
| Listed companies | 1 |
|---|---|
| ENDONOVO THERAPEUTICS, INC. | Health Technology |
| Private companies | 1 |
|---|---|
Regenetech, Inc.
Regenetech, Inc. Miscellaneous Commercial ServicesCommercial Services Regenetech, Inc. develops and distributes tissue regeneration technology. It provides research and development services for adult stem cells expansion and therapeutic applications. The firm offers umbilical cord and peripheral blood expansion, bone regeneration, and biomolecules producing therapeutic technologies. The company was founded in April, 2002 and is headquartered in Houston, TX. | Commercial Services |
- Stock Market
- Insiders
- Donnie Rudd
